OMC
SLDB icon

Oasis Management Company’s Solid Biosciences SLDB Stock Holding History

Oasis Management Company’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-53,333
Closed -$373K – 132
2022
Q3 		$373K Buy
53,333
+38,506
+260% +$388K 0.06% 100
2022
Q2 		$137K Buy
+14,827
New +$154K 0.02% 120

Other funds holding SLDB

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Oasis Management Company's SLDB Position: Q4 2022 in Review

Oasis Management Company sold out of Solid Biosciences (SLDB) in Q4 2022, closing a stake of 53,333 shares — an estimated $373K sold.

Oasis Management Company first reported a position in SLDB in Q2 2022 and held it in 2 quarters. The position peaked at $373K in Q3 2022. 35 funds tracked by Wall St. Rank hold SLDB as of Q4 2022.

  • Oasis Management Company reported no remaining Solid Biosciences position as of Q4 2022 after selling out during the quarter.
  • Oasis Management Company sold 53,333 Solid Biosciences shares in Q4 2022, an estimated $373K.
  • Oasis Management Company first reported a position in Solid Biosciences in Q2 2022 and held it in 2 quarters.
  • Oasis Management Company's Solid Biosciences position peaked at $373K in Q3 2022.
  • 35 funds tracked by Wall St. Rank held Solid Biosciences as of Q4 2022.

Based on Oasis Management Company's 13F filing for Q4 2022, filed 14 Feb 2023.